SG11201805264RA - Infant formula comprising human milk peptides - Google Patents
Infant formula comprising human milk peptidesInfo
- Publication number
- SG11201805264RA SG11201805264RA SG11201805264RA SG11201805264RA SG11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA SG 11201805264R A SG11201805264R A SG 11201805264RA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- infant formula
- peptides
- auckland
- december
- Prior art date
Links
- 235000013350 formula milk Nutrition 0.000 title abstract 3
- 210000004251 human milk Anatomy 0.000 title abstract 2
- 235000020256 human milk Nutrition 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 abstract 3
- 102220547770 Inducible T-cell costimulator_A23L_mutation Human genes 0.000 abstract 1
- 108010065875 beta-casomorphins Proteins 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229960005181 morphine Drugs 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/54—Proteins
- A23V2250/542—Animal Protein
- A23V2250/5424—Dairy protein
- A23V2250/54246—Casein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pediatric Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562270955P | 2015-12-22 | 2015-12-22 | |
| PCT/NZ2016/050203 WO2017111618A1 (en) | 2015-12-22 | 2016-12-21 | Infant formula comprising human milk peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201805264RA true SG11201805264RA (en) | 2018-07-30 |
Family
ID=59090893
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201805264RA SG11201805264RA (en) | 2015-12-22 | 2016-12-21 | Infant formula comprising human milk peptides |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20190000128A1 (es) |
| EP (1) | EP3393493A4 (es) |
| JP (1) | JP2018537997A (es) |
| KR (1) | KR20180096704A (es) |
| CN (1) | CN108472335A (es) |
| AU (1) | AU2016377254A1 (es) |
| BR (1) | BR112018012922A2 (es) |
| CA (1) | CA3009360A1 (es) |
| CL (1) | CL2018001728A1 (es) |
| IL (1) | IL260201A (es) |
| MX (1) | MX2018007819A (es) |
| PH (1) | PH12018550097A1 (es) |
| RU (1) | RU2018123201A (es) |
| SG (1) | SG11201805264RA (es) |
| TW (1) | TW201722295A (es) |
| WO (1) | WO2017111618A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ746167A (en) * | 2016-03-30 | 2023-04-28 | A2 Milk Co Ltd | Beta-caseins and cognitive function |
| BR102019023798A2 (pt) * | 2019-11-12 | 2021-05-25 | José Ferreira Nunes | composto lácteo de água de coco e leite de cabra e uso do composto |
| WO2022002995A1 (en) * | 2020-07-01 | 2022-01-06 | Frieslandcampina Nederland B.V. | Process for the preparation of a powdery composition comprising bioactive molecules |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6020015A (en) * | 1988-09-22 | 2000-02-01 | Gaull; Gerald E. | Infant formula compositions and nutrition containing genetically engineered human milk proteins |
| WO1993004171A1 (en) * | 1991-08-19 | 1993-03-04 | Symbicom Aktiebolag | Human beta-casein, process for producing it and use thereof |
| EP1196047A4 (en) * | 1999-06-29 | 2004-12-22 | New Zealand Milk Inst Ltd | MILK-BASED PROPHYLACTIC FOOD SUPPLEMENTS |
| CN103315063A (zh) * | 2012-03-19 | 2013-09-25 | 基斯有限公司 | 可预防疾病的婴儿配方奶粉 |
| WO2015026245A1 (en) * | 2013-08-23 | 2015-02-26 | The A2 Milk Company Limited | Beta-casein a2 and blood glucose levels |
-
2016
- 2016-12-21 WO PCT/NZ2016/050203 patent/WO2017111618A1/en active Application Filing
- 2016-12-21 JP JP2018532791A patent/JP2018537997A/ja not_active Withdrawn
- 2016-12-21 CA CA3009360A patent/CA3009360A1/en not_active Abandoned
- 2016-12-21 AU AU2016377254A patent/AU2016377254A1/en not_active Abandoned
- 2016-12-21 EP EP16879450.1A patent/EP3393493A4/en not_active Withdrawn
- 2016-12-21 BR BR112018012922A patent/BR112018012922A2/pt not_active Application Discontinuation
- 2016-12-21 MX MX2018007819A patent/MX2018007819A/es unknown
- 2016-12-21 KR KR1020187020586A patent/KR20180096704A/ko unknown
- 2016-12-21 RU RU2018123201A patent/RU2018123201A/ru not_active Application Discontinuation
- 2016-12-21 US US16/065,118 patent/US20190000128A1/en not_active Abandoned
- 2016-12-21 CN CN201680079280.7A patent/CN108472335A/zh active Pending
- 2016-12-21 SG SG11201805264RA patent/SG11201805264RA/en unknown
- 2016-12-22 TW TW105142611A patent/TW201722295A/zh unknown
-
2018
- 2018-06-20 PH PH12018550097A patent/PH12018550097A1/en unknown
- 2018-06-21 IL IL260201A patent/IL260201A/en unknown
- 2018-06-22 CL CL2018001728A patent/CL2018001728A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3393493A1 (en) | 2018-10-31 |
| KR20180096704A (ko) | 2018-08-29 |
| JP2018537997A (ja) | 2018-12-27 |
| IL260201A (en) | 2018-07-31 |
| PH12018550097A1 (en) | 2019-02-11 |
| RU2018123201A3 (es) | 2020-03-02 |
| RU2018123201A (ru) | 2020-01-23 |
| TW201722295A (zh) | 2017-07-01 |
| BR112018012922A2 (pt) | 2018-12-11 |
| MX2018007819A (es) | 2018-12-17 |
| WO2017111618A1 (en) | 2017-06-29 |
| CL2018001728A1 (es) | 2018-09-28 |
| CA3009360A1 (en) | 2017-06-29 |
| US20190000128A1 (en) | 2019-01-03 |
| AU2016377254A1 (en) | 2018-07-12 |
| CN108472335A (zh) | 2018-08-31 |
| EP3393493A4 (en) | 2019-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201901700UA (en) | Biaryl compounds useful as immunomodulators | |
| SG11201900269XA (en) | Channel sensing for independent links | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
| SG11201804758QA (en) | Aqueous pharmaceutical formulation comprising anti-pd-1 antibody avelumab | |
| SG11201807912SA (en) | Vaccine against rsv | |
| SG11201805709RA (en) | Anti-pro/latent myostatin antibodies and methods of use thereof | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201809374VA (en) | Cd40l-fc fusion polypeptides and methods of use thereof | |
| SG11201906436VA (en) | Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same | |
| SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201809594WA (en) | Nicotine particles and compositions | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201807593TA (en) | Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers | |
| SG11201810429UA (en) | Anti-cd19 antibody formulations | |
| SG11201810965YA (en) | 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors | |
| SG11201909807TA (en) | Methods of manufacturing of niraparib | |
| SG11201901995TA (en) | Crystalline and salt forms of ppar agonist compounds | |
| SG11201805204WA (en) | Nicotine particle capsule | |
| SG11201804821PA (en) | A beverage capsule | |
| SG11201903193WA (en) | Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate | |
| SG11201907896PA (en) | Optical system for monitoring the movement of people through a passageway | |
| SG11201806127XA (en) | Pharmaceutical or nutritional combination comprising beta-hydroxy-betamethylbutyrate | |
| SG11201906778RA (en) | Improved methods for assessing risk of developing breast cancer |